Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells
- 30 September 1993
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 17 (9), 749-757
- https://doi.org/10.1016/0145-2126(93)90108-w
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Effect of 5-aza-2′-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cellsCancer Letters, 1990
- RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIAThe Lancet, 1989
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Acute myelogenous leukemia: recent advances in therapyBlood, 1987
- Retinoic acid induced HL-60 myeloid differentiation: Dependence of early and late events on isomeric structureLeukemia Research, 1986
- Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observationsBlood, 1983
- Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implicationsBlood, 1983
- THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1978